{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T05:17:15Z","timestamp":1788671835971,"version":"build-2803163510"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073444"],"award-info":[{"award-number":["82073444"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273537"],"award-info":[{"award-number":["82273537"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Immunology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.molimm.2026.08.009","type":"journal-article","created":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T04:02:54Z","timestamp":1786766574000},"page":"155-167","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Preliminary exploration of effects of the JAK inhibitor tofacitinib on pyoderma gangrenosum: In vitro inhibition of NETs and Th17 differentiation"],"prefix":"10.1016","volume":"198","author":[{"given":"Wenqi","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rupeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianyong","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2901-4273","authenticated-orcid":false,"given":"Zhu","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molimm.2026.08.009_bib1","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jdcr.2020.12.005","article-title":"Guselkumab as a treatment option for recalcitrant pyoderma gangrenosum","volume":"8","author":"Baier","year":"2020","journal-title":"Jaad. Case Rep."},{"issue":"6","key":"10.1016\/j.molimm.2026.08.009_bib2","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.jid.2024.09.023","article-title":"Insights into the pathogenesis of Pyoderma Gangrenosum","volume":"145","author":"Becker","year":"2025","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.molimm.2026.08.009_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.932265","article-title":"From IL-17 to IFN-\u03b3 in inflammatory skin disorders: Is transdifferentiation a potential treatment target?","volume":"13","author":"Belpaire","year":"2022","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.molimm.2026.08.009_bib4","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1007\/s10067-023-06506-x","article-title":"Refractory Takayasu arteritis with recurrent pyoderma gangrenosum: a therapeutic challenge with case-based review","volume":"42","author":"Bhowmick","year":"2023","journal-title":"Clin. Rheumatol."},{"issue":"1890","key":"10.1016\/j.molimm.2026.08.009_bib5","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2022.0249","article-title":"Citrulline is not a major determinant of autoantibody reactivity to neutrophil extracellular traps","volume":"378","author":"de Bont","year":"2023","journal-title":"Philos. Trans. R. Soc. Lond. B. Biol. Sci."},{"issue":"8","key":"10.1016\/j.molimm.2026.08.009_bib6","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1111\/ijd.16676","article-title":"JAK inhibitors: a novel, safe, and efficacious therapy for pyoderma gangrenosum","volume":"62","author":"Castro","year":"2023","journal-title":"Int. J. Dermatol."},{"issue":"6611","key":"10.1016\/j.molimm.2026.08.009_bib7","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1126\/science.abn0478","article-title":"Lineage plasticity in prostate cancer depends on JAK\/STAT inflammatory signaling","volume":"377","author":"Chan","year":"2022","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.molimm.2026.08.009_bib8","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jaad.2021.07.002","article-title":"Janus kinase inhibitors in dermatology: Part I. A comprehensive review","volume":"86","author":"Chapman","year":"2022","journal-title":"J. Am. Acad. Dermatol."},{"issue":"9","key":"10.1016\/j.molimm.2026.08.009_bib9","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.jdcr.2020.07.035","article-title":"Recalcitrant and severe pyoderma gangrenosum attributable to levamisole-adulterated cocaine and treated successfully with oral tofacitinib","volume":"6","author":"Choi","year":"2020","journal-title":"Jaad. Case Rep."},{"issue":"9","key":"10.1016\/j.molimm.2026.08.009_bib10","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1111\/exd.14397","article-title":"Evaluation of neutrophil extracellular trap deregulated formation in pyoderma gangrenosum","volume":"30","author":"Croia","year":"2021","journal-title":"Exp. Dermatol."},{"issue":"1","key":"10.1016\/j.molimm.2026.08.009_bib11","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1136\/annrheumdis-2022-eular.389","article-title":"OP0047\u2005IMPAIRED JAK-STAT PATHWAY IN PATIENTS WITH PYODERMA GANGRENOSUM","volume":"81","author":"Demirci Yildirim","year":"2022","journal-title":"Ann. Rheum. Dis."},{"issue":"12","key":"10.1016\/j.molimm.2026.08.009_bib12","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1007\/s00296-023-05418-y","article-title":"\u0130., 2024. Quantitative analysis of JAK\/STAT signaling pathway in patients of inflammatory skin disorders","volume":"44","author":"Demirci Yildirim","year":"2024","journal-title":"Rheumatol. Int."},{"issue":"3","key":"10.1016\/j.molimm.2026.08.009_bib13","doi-asserted-by":"crossref","first-page":"727","DOI":"10.24272\/j.issn.2095-8137.2026.076","article-title":"Amphibian-derived peptides as novel therapeutics for skin wound healing: Mechanisms, applications, and challenges","volume":"47","author":"Deng","year":"2026","journal-title":"Zool. Res."},{"issue":"1","key":"10.1016\/j.molimm.2026.08.009_bib14","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/14740338.2018.1396316","article-title":"The safety of treatments used in pyoderma gangrenosum","volume":"17","author":"Feldman","year":"2018","journal-title":"Expert. Opin. Drug. Saf."},{"issue":"4","key":"10.1016\/j.molimm.2026.08.009_bib15","doi-asserted-by":"crossref","first-page":"915","DOI":"10.3390\/cells9040915","article-title":"Neutrophil Extracellular Traps (NETs) take the central stage in driving autoimmune responses","volume":"9","author":"Fousert","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.molimm.2026.08.009_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2026.173231","article-title":"The self-assembling amphibian-derived peptide (RADA)4-FZ1 pioneers a novel therapeutic platform for diabetic skin wound management","volume":"530","author":"Fu","year":"2026","journal-title":"Chem. Eng. J."},{"issue":"1","key":"10.1016\/j.molimm.2026.08.009_bib17","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/art.39818","article-title":"Tofacitinib ameliorates murine lupus and its associated vascular dysfunction","volume":"69","author":"Furumoto","year":"2017","journal-title":"Arthritis Rheumatol."},{"issue":"2","key":"10.1016\/j.molimm.2026.08.009_bib18","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1080\/17512433.2020.1709825","article-title":"Diagnosis and novel clinical treatment strategies for pyoderma gangrenosum","volume":"13","author":"Goldust","year":"2020","journal-title":"Expert. Rev. Clin. Pharmacol."},{"key":"10.1016\/j.molimm.2026.08.009_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.111810","article-title":"HIF-1\u03b1 induced by hypoxic condition regulates Treg\/Th17 axis polarization in chronic immune thrombocytopenia","volume":"131","author":"Gu","year":"2024","journal-title":"Int. Immunopharmacol."},{"issue":"9","key":"10.1016\/j.molimm.2026.08.009_bib20","first-page":"e253","article-title":"Dermatological Association Pyoderma Gangrenosum Treatment Guidelines Drafting Committee, 2023. Clinical guidance of pyoderma gangrenosum","volume":"50","author":"Higuchi","year":"2022","journal-title":"J. Dermatol."},{"issue":"8","key":"10.1016\/j.molimm.2026.08.009_bib21","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1001\/jamadermatol.2024.1775","article-title":"Treatment of pyoderma gangrenosum with vilobelimab","volume":"160","author":"Himed","year":"2024","journal-title":"Jama. Dermatol."},{"issue":"6","key":"10.1016\/j.molimm.2026.08.009_bib22","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000894","article-title":"Brain-homing CD4+ T cells display glucocorticoid-resistant features in MS","volume":"7","author":"Koetzier","year":"2020","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"10","key":"10.1016\/j.molimm.2026.08.009_bib23","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1007\/s00296-024-05560-1","article-title":"Tofacitinib therapy for severe pyoderma gangrenosum in a patient with enteropathic arthritis: a case-based review","volume":"44","author":"K\u00f6ken Av\u015far","year":"2024","journal-title":"Rheumatol. Int."},{"issue":"5","key":"10.1016\/j.molimm.2026.08.009_bib24","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.immuni.2019.04.006","article-title":"Fate-Mapping of GM-CSF expression identifies a discrete subset of inflammation-driving t helper cells regulated by cytokines IL-23 and IL-1\u03b2","volume":"50","author":"Komuczki","year":"2019","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.molimm.2026.08.009_bib25","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202216592","article-title":"Targetable Brg1-CXCL14 axis contributes to alcoholic liver injury by driving neutrophil trafficking","volume":"15","author":"Li","year":"2023","journal-title":"Embo. Mol. Med."},{"issue":"6","key":"10.1016\/j.molimm.2026.08.009_bib26","doi-asserted-by":"crossref","first-page":"E41","DOI":"10.1002\/ibd.21684","article-title":"Failure of anakinra treatment of pyoderma gangrenosum in an IBD patient and relevance to the PSTPIP1 gene","volume":"17","author":"Lin","year":"2011","journal-title":"Inflamm. Bowel. Dis."},{"issue":"4","key":"10.1016\/j.molimm.2026.08.009_bib27","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.3390\/ijms25042440","article-title":"The pathophysiology and treatment of pyoderma gangrenosum-current options and new perspectives","volume":"25","author":"\u0141yko","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"15","key":"10.1016\/j.molimm.2026.08.009_bib28","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1007\/s00018-019-03331-x","article-title":"Nitric oxide and peroxynitrite trigger and enhance release of neutrophil extracellular traps","volume":"77","author":"Manda-Handzlik","year":"2020","journal-title":"Cell. Mol. Life. Sci."},{"issue":"4","key":"10.1016\/j.molimm.2026.08.009_bib29","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/imcb.12015","article-title":"The influence of agents differentiating HL-60 cells toward granulocyte-like cells on their ability to release neutrophil extracellular traps","volume":"96","author":"Manda-Handzlik","year":"2018","journal-title":"Immunol. Cell. Biol."},{"issue":"5","key":"10.1016\/j.molimm.2026.08.009_bib30","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s40257-022-00699-8","article-title":"Pyoderma Gangrenosum: an updated literature review on established and emerging pharmacological treatments","volume":"23","author":"Maronese","year":"2022","journal-title":"Am. J. Clin. Dermatol."},{"issue":"4","key":"10.1016\/j.molimm.2026.08.009_bib31","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/imm.13124","article-title":"Biological and clinical significance of T helper 17 cell plasticity","volume":"158","author":"Mazzoni","year":"2019","journal-title":"Immunology"},{"issue":"4","key":"10.1016\/j.molimm.2026.08.009_bib32","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.jaci.2022.04.027","article-title":"Single-cell analysis implicates TH17-to-TH2 cell plasticity in the pathogenesis of palmoplantar pustulosis","volume":"150","author":"McCluskey","year":"2022","journal-title":"J. Allergy Clin. Immunol."},{"issue":"8","key":"10.1016\/j.molimm.2026.08.009_bib33","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1007\/s10067-022-06202-2","article-title":"Th17.1 lymphocytes: emerging players in the orchestra of immune-mediated inflammatory diseases","volume":"41","author":"Misra","year":"2022","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.molimm.2026.08.009_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1174249","article-title":"Arterial wall fibrosis in Takayasu arteritis and its potential for therapeutic modulation","volume":"14","author":"Misra","year":"2023","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.molimm.2026.08.009_bib35","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/s12016-020-08804-7","article-title":"A Review of Neutrophil Extracellular Traps (NETs) in disease: potential anti-NETs Therapeutics","volume":"61","author":"Mutua","year":"2021","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.molimm.2026.08.009_bib36","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jdcr.2021.08.021","article-title":"Pyoderma gangrenosum in a patient on ixekizumab","volume":"16","author":"Pollack","year":"2021","journal-title":"Jaad. Case Rep."},{"issue":"5","key":"10.1016\/j.molimm.2026.08.009_bib37","first-page":"1187","article-title":"Ultra-short cyclic peptide Cy RL-QN15 acts as a TLR4 antagonist to expedite oral ulcer healing","volume":"46","author":"Ru","year":"2025","journal-title":"Zool. Res."},{"issue":"5","key":"10.1016\/j.molimm.2026.08.009_bib38","doi-asserted-by":"crossref","first-page":"e660","DOI":"10.1111\/jdv.18683","article-title":"The role of interleukins 6, 8, 17 and 23 in the pathogenesis of pyoderma gangrenosum","volume":"37","author":"Rubas","year":"2023","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.molimm.2026.08.009_bib39","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.2147\/JIR.S355881","article-title":"Novel Th17 Lymphocyte Populations, Th17.1 and PD1+Th17, are Increased in Takayasu Arteritis, and Both Th17 and Th17.1 sub-populations associate with active disease","volume":"15","author":"Singh","year":"2022","journal-title":"J. Inflamm. Res."},{"issue":"9","key":"10.1016\/j.molimm.2026.08.009_bib40","first-page":"36","article-title":"Non-response to Interleukin-1 antagonist canakinumab in two patients with refractory pyoderma gangrenosum and hidradenitis suppurativa","volume":"10","author":"Sun","year":"2017","journal-title":"J. Clin. Aesthet. Dermatol. 2017"},{"issue":"4","key":"10.1016\/j.molimm.2026.08.009_bib41","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/JLB.3RU0620-375R","article-title":"The vitals of NETs","volume":"110","author":"Tan","year":"2021","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.molimm.2026.08.009_bib42","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1146\/annurev-cellbio-020520-111016","article-title":"Cellular *isms of NETosis","volume":"36","author":"Thiam","year":"2020","journal-title":"Annu. Rev. Cell. Dev. Biol."},{"issue":"8","key":"10.1016\/j.molimm.2026.08.009_bib43","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/s41577-020-00490-y","article-title":"Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity","volume":"21","author":"Veglia","year":"2021","journal-title":"Nat. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.molimm.2026.08.009_bib44","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1684\/ejd.2015.2526","article-title":"Late paradoxical development of pyoderma gangrenosum in a psoriasis patient treated with infliximab","volume":"25","author":"Vestita","year":"2015","journal-title":"Eur. J. Dermatol."},{"key":"10.1016\/j.molimm.2026.08.009_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.109448","article-title":"Protein kinase C isoforms mediate the formation of neutrophil extracellular traps","volume":"114","author":"Vorobjeva","year":"2023","journal-title":"Int. Immunopharmacol."},{"issue":"18","key":"10.1016\/j.molimm.2026.08.009_bib46","doi-asserted-by":"crossref","first-page":"19503","DOI":"10.1021\/acs.jmedchem.5c01734","article-title":"Cyclic Heptapeptide FZ1 Acts as an Integrin \u03b1v\u03b23 agonist to facilitate diabetic skin wound healing by enhancing angiogenesis","volume":"68","author":"Wang","year":"2025","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.molimm.2026.08.009_bib47","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jid.2023.06.204","article-title":"NETosis is induced by complement component 5a: implications in the pathogenesis of Pyoderma Gangrenosum","volume":"144","author":"Wang","year":"2024","journal-title":"J. Invest. Dermatol."},{"issue":"13","key":"10.1016\/j.molimm.2026.08.009_bib48","doi-asserted-by":"crossref","first-page":"10476","DOI":"10.3390\/ijms241310476","article-title":"The synergistic effect of proanthocyanidin and HDAC inhibitor inhibit breast cancer cell growth and promote apoptosis","volume":"24","author":"Wang","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.molimm.2026.08.009_bib49","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.24272\/j.issn.2095-8137.2024.134","article-title":"Peptide Cy RL-QN15 accelerates hair regeneration in diabetic mice by binding to the Frizzled-7 receptor","volume":"45","author":"Wu","year":"2024","journal-title":"Zool. Res."},{"issue":"Pt B","key":"10.1016\/j.molimm.2026.08.009_bib50","article-title":"The lncRNA HOTAIR via miR-17-5p is involved in arsenite-induced hepatic fibrosis through regulation of Th17 cell differentiation","volume":"443","author":"Wu","year":"2023","journal-title":"J. Hazard. Mater."},{"key":"10.1016\/j.molimm.2026.08.009_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdermsci.2019.11.012","article-title":"Transcriptome landscape of myeloid cells in human skin reveals diversity, rare populations and putative DC progenitors","author":"Xue","year":"2020","journal-title":"J. Dermatol. Sci. 97(1)41-49."},{"issue":"1","key":"10.1016\/j.molimm.2026.08.009_bib52","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/s41392-023-01468-7","article-title":"Evolving cognition of the JAK-STAT signaling pathway: autoimmune disorders and cancer","volume":"8","author":"Xue","year":"2023","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"16","key":"10.1016\/j.molimm.2026.08.009_bib53","doi-asserted-by":"crossref","first-page":"8757","DOI":"10.3390\/ijms25168757","article-title":"Sodium Acetate enhances neutrophil extracellular trap formation via histone acetylation pathway in neutrophil-like HL-60 Cells","volume":"25","author":"Yasuda","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.molimm.2026.08.009_bib54","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/all.15486","article-title":"Single-cell profiles reveal distinctive immune response in atopic dermatitis in contrast to psoriasis","volume":"78","author":"Zhang","year":"2023","journal-title":"Allergy"}],"container-title":["Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589026001896?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589026001896?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T05:03:37Z","timestamp":1788671017000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161589026001896"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":54,"alternative-id":["S0161589026001896"],"URL":"https:\/\/doi.org\/10.1016\/j.molimm.2026.08.009","relation":{},"ISSN":["0161-5890"],"issn-type":[{"value":"0161-5890","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preliminary exploration of effects of the JAK inhibitor tofacitinib on pyoderma gangrenosum: In vitro inhibition of NETs and Th17 differentiation","name":"articletitle","label":"Article Title"},{"value":"Molecular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molimm.2026.08.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}